IVL-Facilitated Transfemoral TAVR
Study Now Published
MINIMIZE TRAUMA – Minimize trauma to soft tissue by safely selecting and fracturing intimal and medial calcium
OPTIMIZE OUTCOMES – Optimize outcomes while reducing complications and cost escalation
SIMPLIFY PROCEDURES – Simple and intuitive system that makes complex calcified procedures more predictable
The First Applications of
Learn more about the potential of IVL in patients with aortic stenosis (AS) or IVL as a means to facilitate transfemoral access and avoid alternative routes by clicking on one of the below:
Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.
Read Dr. @naransonmd's experience using #ShockwaveIVL for aortoiliac occlusive disease (#AIOD) in this “kissing” bi… https://t.co/u5wlObaRNT
What a difference! Great #ShockwaveIVL case by Dr. George Chrysant in Oklahoma City!
CTO of #SFA, 6.0x60… https://t.co/QuhHmCiwYB
Have you used #ShockwaveIVL as a safe & cost-effective solution for challenging #iliac calcium? What about #EVAR/… https://t.co/xTpa4VtFYa
Congrats, Mr. Said Abisi on performing the 1st #ShockwaveS4 case of the int'l LMR at St. Thomas’s Hospital in Londo… https://t.co/Fz0oX8L1tu
Hear how Dr. @FotehMazinMD treats calcified #iliac stenosis using #IntravascularLithotripsy to facilitate percutane… https://t.co/gpunKuPaOs
Thanks, @EpsVascular for sharing this excellent #SFA result using #ShockwaveIVL. Well done, Dr. Matti Vähäkari with… https://t.co/EHHy8kDsNj
Familiar with the challenges of calcified #BTK disease? Hear Dr. Melissa Loja share her thoughts on #IVL for treatm… https://t.co/mKTXN1eAzf
The only thing we love more than the Friday before a long weekend is an excellent #ShockwaveIVL result! Densely cal… https://t.co/8MqDqLhz9V
As the #DISRUPTCAD3 trial results are eagerly awaited, read key takeaways from Dr. @djkereiakes, co-PI of the coron… https://t.co/25xn5h38ye
Check out the #ESCCongress ePoster presentation by Dr. Giulia Nardi on intravascular imaging to guide #ShockwaveIVL… https://t.co/SLrna3I9Ej
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.
